On combining data from genome-wide association studies to discover disease-associated SNPs

Statistical Science

Volumn 24, Issue 4, 2009, Pages 547-560

  Pfeiffer, Ruth M ^a   Gail, Mitchell H ^a   Pee, David ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b INFORMATION MANAGEMENT SERVICES INC   (United States)

Author keywords

Hypothesis testing; Multiple comparison; Random effects; Wald test; Whole genome scans

Indexed keywords

EID: 77955151338     PISSN: 08834237     EISSN: None     Source Type: Journal    
DOI: 10.1214/09-STS286     Document Type: Article

References (18)

1. ARMITAGE, P. (1955). Tests for linear trends in proportions and frequencies. Biometrics 11 375-386.
2. DERSIMONIAN, R. and LAIRD, N. (1986). Meta-analysis in clinical trials. Control. Clin. Trials 7 177-188.
3. DEVLIN, B. and ROEDER, K. (1999). Genomic control for association studies. Biometrics 55 997-1004.
4. EASTON, D.F., POOLEY, K.A., DUNNING, A. M. et al. (2007). Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 28 1087-1093.
5. FISHER, R. A. (1932). Statistical Methods for Research Workers, 4th ed. Oliver and Boyd, London
6. FOLLMANN, D.A. and PROSCHAN, M. A. (1999). Valid inference in random effects meta-analysis. Biometrics 55 732-737.
7. GAIL, M.H., PFEIFFER, R.M., WHEELER, W. and PEE, D. (2008a). Probability of detecting disease-associated single nucleotide polymorphisms in case-control genome-wide association studies. Biostatistics 9 201-215.
8. GAIL, M.H., PFEIFFER, R.M., WHEELER, W. and PEE, D. (2008b). Probability that a two-stage genome-wide association study will detect a disease-associated SNP and implications for multistage designs. Ann. Hum. Genet. 72 812-820.
9. LIPTAK, T. (1958). On the combination of independent tests. Magyar Tudomanyos Akademia Matematikai Kutato Intezetenek Kozlemenyei 3 1971-1977.
10. LOUGHIN, T. M. (2004). A systematic comparison of methods for combining p-values from independent tests. Comput. Statist. Data Anal. 47 467-485. MR2086483
11. MANTEL, N. and HAENSZEL, W. (1959). Statistical aspects of the analysis of data from retrospective studies of disease. J. Natl. Cancer Inst. 22 719-748.
12. PFEIFFER, R.M. and GAIL, M. H. (2003). Sample size calculations for populationand family-based case-control association studies on marker genotypes. Genet. Epidemiol. 25 136-148.
13. SASIENI, P. D. (1997). From genotypes to genes: Doubling the sample size. Biometrics 53 1253-1261. MR1614374
14. SKOL, A.D., SCOTT, L.J., ABACASIS, G.R. and BOEHNKE, M. (2007). Optimal designs for two-stage genome-wide association studies. Genet. Epidemiol. 31 776-788.
15. SKOL, A.D., SCOTT, L.J., ABACASIS, G.R. and BOEHNKE, M. (2006). Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies. Nat. Genet. 38 209-213.
16. YUSUF, S., PETO, R., LEWIS, J., COLLINS, R. and SLEIGHT, P. (1985). Beta blockade during and after myocardial infarction: An overview of the randomized trials. Prog. Cardiovasc. Dis. 27 335-371.
17. YEAGER, M., ORR, N., HAYES, R. B. et al. (2007). Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat. Genet. 39 645-649.
18. ZEGGINI, E., SCOTT, L.J., SAXENA, R. et al. (2008). Metaanalysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat. Genet. 40 638-645.